| Identification | Back Directory | [Name]
Sorafenib 13C D3 | [CAS]
1210608-86-8 | [Synonyms]
Sorafenib 13C D3
[13C,2H3]-Sorafenib
4-[4-[[4-Chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-(trideuteriomethyl-13C)pyridine-2-carboxamide
Sorafenib 13C D3Q: What is
Sorafenib 13C D3 Q: What is the CAS Number of
Sorafenib 13C D3 Q: What is the storage condition of
Sorafenib 13C D3 Q: What are the applications of
Sorafenib 13C D3 | [Molecular Formula]
C21H13ClD3F3N4O3 | [MOL File]
1210608-86-8.mol | [Molecular Weight]
468.852 |
| Hazard Information | Back Directory | [Uses]
Sorafenib 13C D3 can be intended for use as an internal standard for the quantification of Sorafenib by GC- or LC-mass spectrometry.
| [Definition]
ChEBI: Sorafenib is a member of the class of phenylureas that is urea in which one of the nitrogens is substituted by a 4-chloro-3-trifluorophenyl group while the other is substituted by a phenyl group which, in turn, is substituted at the para position by a [2-(methylcarbamoyl)pyridin-4-yl]oxy group. It has a role as an antineoplastic agent, an EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor, a tyrosine kinase inhibitor, an angiogenesis inhibitor, an anticoronaviral agent and a ferroptosis inducer. It is a pyridinecarboxamide, a member of monochlorobenzenes, an aromatic ether, a member of (trifluoromethyl)benzenes and a member of phenylureas. |
|
|